Compound 1790
Identifiers
- Canonical SMILES:
CC(=O)c1cc(-c2cccc3nccn23)c2cc(ccn12)N1CCOCC1
- IUPAC name:
1-(1-{imidazo[1,2-a]pyridin-5-yl}-7-(morpholin-4-yl)indolizin-3-yl)ethan-1-one
- InChi:
InChI=1S/C21H20N4O2/c1-15(26)19-14-17(18-3-2-4-21-22-6-8-25(18)21)20-13-16(5-7-24(19)20)23-9-11-27-12-10-23/h2-8,13-14H,9-12H2,1H3
- InChiKey:
LBUBPCSKFDKKFO-UHFFFAOYSA-N
External links
![]() 127038798 |
![]() CHEMBL3740819 |
5L0 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Wang Na, Li Fudong, Bao Hongyu, Li Jie, Wu Jihui, Ruan Ke. . NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains ChemBioChem. | 8 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 7.17 | hepatocellular clear cell carcinoma , non-small cell lung carcinoma (disease) | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 360.16 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 1.33 | |||
TPSA | 51.25 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1002/cbic.201600184 | 8 | BRD9 Q9H8M2 |
H4 P62805 |
Biochemical assay | Isothermal Titration Calorimetry | pKd (dissociation constant, -log10) | 7.17 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6185 | N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide | DB06834 | |
0.5521 | Vistusertib | DB11925 | |
0.5279 | WNT-974 | DB12561 | |
0.5269 | Linsitinib | DB06075 | |
0.5110 | 3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE | DB07655 | |
0.5070 | JNJ-42396302 | DB12657 | |
0.5000 | (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL | DB07647 | |
0.5000 | 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DB08358 | |
0.4974 | Entospletinib | DB12121 | |
0.4972 | Mocetinostat | DB11830 | |
0.4922 | (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL | DB07648 | |
0.4901 | AZD-8055 | DB12774 | |
0.4861 | Lorecivivint | DB14883 | |
0.4813 | Zolpidem | DB00425 | |
0.4812 | [4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid | DB07837 |